ACKR3 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "ACKR3" in English language version.

refsWebsite

Global rank English rank

20nih.gov

4^th place

11doi.org

2^nd place

4harvard.edu

18^th place

17^th place

3semanticscholar.org

11^th place

8^th place

2ensembl.org

1,626^th place

1,007^th place

1handle.net

102^nd place

76^th place

1biorxiv.org

5,061^st place

5,698^th place

biorxiv.org

Zarca AM, Adlere I, Viciano CP, Arimont-Segura M, Meyrath M, Simon IA, Bebelman JP, Laan D, Custers HG, Janssen E, Versteegh KL, Buzink MC, Nesheva DN, Bosma R, de Esch IJ, Vischer HF, Wijtmans M, Szpakowska M, Chevigné A, Hoffmann C, de Graaf C, Zarzycka BA, Windhorst AD, Smit MJ, Leurs R (March 2024). "Pharmacological Characterization and Radiolabeling of VUF15485, a High-Affinity Small-Molecule Agonist for the Atypical Chemokine Receptor ACKR3" (PDF). Mol Pharmacol. 105 (4): 301–312. doi:10.1124/molpharm.123.000835. PMID 38346795.

doi.org

Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B, et al. (October 2005). "The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes". The Journal of Biological Chemistry. 280 (42): 35760–35766. doi:10.1074/jbc.M508234200. PMID 16107333.
Fumagalli A, Zarca A, Neves M, Caspar B, Hill SJ, Mayor F, et al. (December 2019). "CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status". Molecular Pharmacology. 96 (6): 794–808. doi:10.1124/mol.118.115360. hdl:10261/214032. PMID 30837297. S2CID 73513931.
* Rajagopal S, Kim J, Ahn S, Craig S, Lam CM, Gerard NP, et al. (January 2010). "Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7". Proceedings of the National Academy of Sciences of the United States of America. 107 (2): 628–632. Bibcode:2010PNAS..107..628R. doi:10.1073/pnas.0912852107. PMC 2818968. PMID 20018651.
Meyrath M, Szpakowska M, Zeiner J, Massotte L, Merz MP, Benkel T, et al. (June 2020). "The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides". Nature Communications. 11 (1): 3033. Bibcode:2020NatCo..11.3033M. doi:10.1038/s41467-020-16664-0. PMC 7305236. PMID 32561830.
Bachelerie F, Graham GJ, Locati M, Mantovani A, Murphy PM, Nibbs R, et al. (March 2014). "New nomenclature for atypical chemokine receptors". Nature Immunology. 15 (3): 207–208. doi:10.1038/ni.2812. PMID 24549061. S2CID 205367583.
Rajagopal S, Kim J, Ahn S, Craig S, Lam CM, Gerard NP, et al. (January 2010). "Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7". Proceedings of the National Academy of Sciences of the United States of America. 107 (2): 628–632. Bibcode:2010PNAS..107..628R. doi:10.1073/pnas.0912852107. PMC 2818968. PMID 20018651.
Koch C, Engele J (November 2020). "Functions of the CXCL12 Receptor ACKR3/CXCR7-What Has Been Perceived and What Has Been Overlooked". Molecular Pharmacology. 98 (5): 577–585. doi:10.1124/molpharm.120.000056. PMID 32883765. S2CID 221498026.
Pance K, Gramespacher JA, Byrnes JR, Salangsang F, Serrano JC, Cotton AD, et al. (February 2023). "Modular cytokine receptor-targeting chimeras for targeted degradation of cell surface and extracellular proteins". Nature Biotechnology. 41 (2): 273–281. doi:10.1038/s41587-022-01456-2. PMC 9931583. PMID 36138170.
Meyrath M, Szpakowska M, Zeiner J, Massotte L, Merz MP, Benkel T, et al. (June 2020). "The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides". Nature Communications. 11 (1): 3033. Bibcode:2020NatCo..11.3033M. doi:10.1038/s41467-020-16664-0. PMC 7305236. PMID 32561830.
Szpakowska M, Decker AM, Meyrath M, Palmer CB, Blough BE, Namjoshi OA, Chevigné A (June 2021). "The natural analgesic conolidine targets the newly identified opioid scavenger ACKR3/CXCR7". Signal Transduct Target Ther. 6 (1): 209. doi:10.1038/s41392-021-00548-w. PMC 8169647. PMID 34075018.
Zarca AM, Adlere I, Viciano CP, Arimont-Segura M, Meyrath M, Simon IA, Bebelman JP, Laan D, Custers HG, Janssen E, Versteegh KL, Buzink MC, Nesheva DN, Bosma R, de Esch IJ, Vischer HF, Wijtmans M, Szpakowska M, Chevigné A, Hoffmann C, de Graaf C, Zarzycka BA, Windhorst AD, Smit MJ, Leurs R (March 2024). "Pharmacological Characterization and Radiolabeling of VUF15485, a High-Affinity Small-Molecule Agonist for the Atypical Chemokine Receptor ACKR3" (PDF). Mol Pharmacol. 105 (4): 301–312. doi:10.1124/molpharm.123.000835. PMID 38346795.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000144476 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000044337 – Ensembl, May 2017

handle.net

hdl.handle.net

Fumagalli A, Zarca A, Neves M, Caspar B, Hill SJ, Mayor F, et al. (December 2019). "CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status". Molecular Pharmacology. 96 (6): 794–808. doi:10.1124/mol.118.115360. hdl:10261/214032. PMID 30837297. S2CID 73513931.

harvard.edu

ui.adsabs.harvard.edu

* Rajagopal S, Kim J, Ahn S, Craig S, Lam CM, Gerard NP, et al. (January 2010). "Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7". Proceedings of the National Academy of Sciences of the United States of America. 107 (2): 628–632. Bibcode:2010PNAS..107..628R. doi:10.1073/pnas.0912852107. PMC 2818968. PMID 20018651.
Meyrath M, Szpakowska M, Zeiner J, Massotte L, Merz MP, Benkel T, et al. (June 2020). "The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides". Nature Communications. 11 (1): 3033. Bibcode:2020NatCo..11.3033M. doi:10.1038/s41467-020-16664-0. PMC 7305236. PMID 32561830.
Rajagopal S, Kim J, Ahn S, Craig S, Lam CM, Gerard NP, et al. (January 2010). "Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7". Proceedings of the National Academy of Sciences of the United States of America. 107 (2): 628–632. Bibcode:2010PNAS..107..628R. doi:10.1073/pnas.0912852107. PMC 2818968. PMID 20018651.
Meyrath M, Szpakowska M, Zeiner J, Massotte L, Merz MP, Benkel T, et al. (June 2020). "The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides". Nature Communications. 11 (1): 3033. Bibcode:2020NatCo..11.3033M. doi:10.1038/s41467-020-16664-0. PMC 7305236. PMID 32561830.

nih.gov

pubmed.ncbi.nlm.nih.gov

Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B, et al. (October 2005). "The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes". The Journal of Biological Chemistry. 280 (42): 35760–35766. doi:10.1074/jbc.M508234200. PMID 16107333.
Fumagalli A, Zarca A, Neves M, Caspar B, Hill SJ, Mayor F, et al. (December 2019). "CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status". Molecular Pharmacology. 96 (6): 794–808. doi:10.1124/mol.118.115360. hdl:10261/214032. PMID 30837297. S2CID 73513931.
* Rajagopal S, Kim J, Ahn S, Craig S, Lam CM, Gerard NP, et al. (January 2010). "Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7". Proceedings of the National Academy of Sciences of the United States of America. 107 (2): 628–632. Bibcode:2010PNAS..107..628R. doi:10.1073/pnas.0912852107. PMC 2818968. PMID 20018651.
Meyrath M, Szpakowska M, Zeiner J, Massotte L, Merz MP, Benkel T, et al. (June 2020). "The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides". Nature Communications. 11 (1): 3033. Bibcode:2020NatCo..11.3033M. doi:10.1038/s41467-020-16664-0. PMC 7305236. PMID 32561830.
Bachelerie F, Graham GJ, Locati M, Mantovani A, Murphy PM, Nibbs R, et al. (March 2014). "New nomenclature for atypical chemokine receptors". Nature Immunology. 15 (3): 207–208. doi:10.1038/ni.2812. PMID 24549061. S2CID 205367583.
Rajagopal S, Kim J, Ahn S, Craig S, Lam CM, Gerard NP, et al. (January 2010). "Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7". Proceedings of the National Academy of Sciences of the United States of America. 107 (2): 628–632. Bibcode:2010PNAS..107..628R. doi:10.1073/pnas.0912852107. PMC 2818968. PMID 20018651.
Koch C, Engele J (November 2020). "Functions of the CXCL12 Receptor ACKR3/CXCR7-What Has Been Perceived and What Has Been Overlooked". Molecular Pharmacology. 98 (5): 577–585. doi:10.1124/molpharm.120.000056. PMID 32883765. S2CID 221498026.
Pance K, Gramespacher JA, Byrnes JR, Salangsang F, Serrano JC, Cotton AD, et al. (February 2023). "Modular cytokine receptor-targeting chimeras for targeted degradation of cell surface and extracellular proteins". Nature Biotechnology. 41 (2): 273–281. doi:10.1038/s41587-022-01456-2. PMC 9931583. PMID 36138170.
Meyrath M, Szpakowska M, Zeiner J, Massotte L, Merz MP, Benkel T, et al. (June 2020). "The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides". Nature Communications. 11 (1): 3033. Bibcode:2020NatCo..11.3033M. doi:10.1038/s41467-020-16664-0. PMC 7305236. PMID 32561830.
Szpakowska M, Decker AM, Meyrath M, Palmer CB, Blough BE, Namjoshi OA, Chevigné A (June 2021). "The natural analgesic conolidine targets the newly identified opioid scavenger ACKR3/CXCR7". Signal Transduct Target Ther. 6 (1): 209. doi:10.1038/s41392-021-00548-w. PMC 8169647. PMID 34075018.
Zarca AM, Adlere I, Viciano CP, Arimont-Segura M, Meyrath M, Simon IA, Bebelman JP, Laan D, Custers HG, Janssen E, Versteegh KL, Buzink MC, Nesheva DN, Bosma R, de Esch IJ, Vischer HF, Wijtmans M, Szpakowska M, Chevigné A, Hoffmann C, de Graaf C, Zarzycka BA, Windhorst AD, Smit MJ, Leurs R (March 2024). "Pharmacological Characterization and Radiolabeling of VUF15485, a High-Affinity Small-Molecule Agonist for the Atypical Chemokine Receptor ACKR3" (PDF). Mol Pharmacol. 105 (4): 301–312. doi:10.1124/molpharm.123.000835. PMID 38346795.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Entrez Gene: CXCR7 chemokine (C-X-C motif) receptor 7".
* Rajagopal S, Kim J, Ahn S, Craig S, Lam CM, Gerard NP, et al. (January 2010). "Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7". Proceedings of the National Academy of Sciences of the United States of America. 107 (2): 628–632. Bibcode:2010PNAS..107..628R. doi:10.1073/pnas.0912852107. PMC 2818968. PMID 20018651.
Meyrath M, Szpakowska M, Zeiner J, Massotte L, Merz MP, Benkel T, et al. (June 2020). "The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides". Nature Communications. 11 (1): 3033. Bibcode:2020NatCo..11.3033M. doi:10.1038/s41467-020-16664-0. PMC 7305236. PMID 32561830.
Rajagopal S, Kim J, Ahn S, Craig S, Lam CM, Gerard NP, et al. (January 2010). "Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7". Proceedings of the National Academy of Sciences of the United States of America. 107 (2): 628–632. Bibcode:2010PNAS..107..628R. doi:10.1073/pnas.0912852107. PMC 2818968. PMID 20018651.
Pance K, Gramespacher JA, Byrnes JR, Salangsang F, Serrano JC, Cotton AD, et al. (February 2023). "Modular cytokine receptor-targeting chimeras for targeted degradation of cell surface and extracellular proteins". Nature Biotechnology. 41 (2): 273–281. doi:10.1038/s41587-022-01456-2. PMC 9931583. PMID 36138170.
Meyrath M, Szpakowska M, Zeiner J, Massotte L, Merz MP, Benkel T, et al. (June 2020). "The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides". Nature Communications. 11 (1): 3033. Bibcode:2020NatCo..11.3033M. doi:10.1038/s41467-020-16664-0. PMC 7305236. PMID 32561830.
Szpakowska M, Decker AM, Meyrath M, Palmer CB, Blough BE, Namjoshi OA, Chevigné A (June 2021). "The natural analgesic conolidine targets the newly identified opioid scavenger ACKR3/CXCR7". Signal Transduct Target Ther. 6 (1): 209. doi:10.1038/s41392-021-00548-w. PMC 8169647. PMID 34075018.

semanticscholar.org

api.semanticscholar.org

Fumagalli A, Zarca A, Neves M, Caspar B, Hill SJ, Mayor F, et al. (December 2019). "CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status". Molecular Pharmacology. 96 (6): 794–808. doi:10.1124/mol.118.115360. hdl:10261/214032. PMID 30837297. S2CID 73513931.
Bachelerie F, Graham GJ, Locati M, Mantovani A, Murphy PM, Nibbs R, et al. (March 2014). "New nomenclature for atypical chemokine receptors". Nature Immunology. 15 (3): 207–208. doi:10.1038/ni.2812. PMID 24549061. S2CID 205367583.
Koch C, Engele J (November 2020). "Functions of the CXCL12 Receptor ACKR3/CXCR7-What Has Been Perceived and What Has Been Overlooked". Molecular Pharmacology. 98 (5): 577–585. doi:10.1124/molpharm.120.000056. PMID 32883765. S2CID 221498026.